Medisch-farmaceutische mededelingen最新文献

筛选
英文 中文
The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach. 糖尿病对法国国家医疗保险造成的经济负担:基于综合医疗和增量方法的新疾病成本法。
Medisch-farmaceutische mededelingen Pub Date : 2018-03-01 Epub Date: 2017-02-11 DOI: 10.1007/s10198-017-0873-y
Grégoire de Lagasnerie, Anne-Sophie Aguadé, Pierre Denis, Anne Fagot-Campagna, Christelle Gastaldi-Menager
{"title":"The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach.","authors":"Grégoire de Lagasnerie, Anne-Sophie Aguadé, Pierre Denis, Anne Fagot-Campagna, Christelle Gastaldi-Menager","doi":"10.1007/s10198-017-0873-y","DOIUrl":"10.1007/s10198-017-0873-y","url":null,"abstract":"<p><p>A better understanding of the economic burden of diabetes constitutes a major public health challenge in order to design new ways to curb diabetes health care expenditure. The aim of this study was to develop a new cost-of-illness method in order to assess the specific and nonspecific costs of diabetes from a public payer perspective. Using medical and administrative data from the major French national health insurance system covering about 59 million individuals in 2012, we identified people with diabetes and then estimated the economic burden of diabetes. Various methods were used: (a) global cost of patients with diabetes, (b) cost of treatment directly related to diabetes (i.e., 'medicalized approach'), (c) incremental regression-based approach, (d) incremental matched-control approach, and (e) a novel combination of the 'medicalized approach' and the 'incremental matched-control' approach. We identified 3 million individuals with diabetes (5% of the population). The total expenditure of this population amounted to €19 billion, representing 15% of total expenditure reimbursed to the entire population. Of the total expenditure, €10 billion (52%) was considered to be attributable to diabetes care: €2.3 billion (23% of €10 billion) was directly attributable, and €7.7 billion was attributable to additional reimbursed expenditure indirectly related to diabetes (77%). Inpatient care represented the major part of the expenditure attributable to diabetes care (22%) together with drugs (20%) and medical auxiliaries (15%). Antidiabetic drugs represented an expenditure of about €1.1 billion, accounting for 49% of all diabetes-specific expenditure. This study shows the economic impact of the assumption concerning definition of costs on evaluation of the economic burden of diabetes. The proposed new cost-of-illness method provides specific insight for policy-makers to enhance diabetes management and assess the opportunity costs of diabetes complications' management programs.</p>","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"46 1","pages":"189-201"},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73494914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Werkzaamheid van dabigatran ten opzichte van warfarine bij mensen met atriumfibrilleren 达比加川对房颤患者华法林的疗效
Medisch-farmaceutische mededelingen Pub Date : 2009-10-01 DOI: 10.1007/BF03080060
E. V. Does
{"title":"Werkzaamheid van dabigatran ten opzichte van warfarine bij mensen met atriumfibrilleren","authors":"E. V. Does","doi":"10.1007/BF03080060","DOIUrl":"https://doi.org/10.1007/BF03080060","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"159-160"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080060","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51872865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Behandeling met insuline: kan het beter? 胰岛素治疗:可以更好吗?
Medisch-farmaceutische mededelingen Pub Date : 2009-10-01 DOI: 10.1007/BF03080058
T. V. Gelder
{"title":"Behandeling met insuline: kan het beter?","authors":"T. V. Gelder","doi":"10.1007/BF03080058","DOIUrl":"https://doi.org/10.1007/BF03080058","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"158-158"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080058","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51872818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuraminidase remmers voor de behandeling en profylaxe van influenza bij kinderen: systematisch overzicht en meta-analyse van gerandomiseerd gecontroleerd onderzoek 用于治疗和预防儿童流感的神经衰减酶抑制剂:随机对照试验的系统综述和荟萃分析
Medisch-farmaceutische mededelingen Pub Date : 2009-10-01 DOI: 10.1007/BF03080059
P. L. Bruijnzeel
{"title":"Neuraminidase remmers voor de behandeling en profylaxe van influenza bij kinderen: systematisch overzicht en meta-analyse van gerandomiseerd gecontroleerd onderzoek","authors":"P. L. Bruijnzeel","doi":"10.1007/BF03080059","DOIUrl":"https://doi.org/10.1007/BF03080059","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"1 1","pages":"158-159"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080059","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51872839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
De polypil voor hen die nog niets mankeren 给那些什么都不缺的人的药丸
Medisch-farmaceutische mededelingen Pub Date : 2009-10-01 DOI: 10.1007/BF03080053
E. V. Does
{"title":"De polypil voor hen die nog niets mankeren","authors":"E. V. Does","doi":"10.1007/BF03080053","DOIUrl":"https://doi.org/10.1007/BF03080053","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"154-155"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080053","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51872732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetische ketoacidose door blootstelling van insulinepomp aan zonlicht 糖尿病酮酸中毒由于暴露在阳光下的胰岛素泵
Medisch-farmaceutische mededelingen Pub Date : 2009-10-01 DOI: 10.1007/BF03080057
M. L. Becker
{"title":"Diabetische ketoacidose door blootstelling van insulinepomp aan zonlicht","authors":"M. L. Becker","doi":"10.1007/BF03080057","DOIUrl":"https://doi.org/10.1007/BF03080057","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"157-158"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080057","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51872812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Invloed van cytochroom P450 2C19 genotype op de effectiviteit van clopidogrel 细胞色素P450 2C19基因型对氯吡格雷有效性的影响
Medisch-farmaceutische mededelingen Pub Date : 2009-10-01 DOI: 10.1007/BF03080061
P. Klaver
{"title":"Invloed van cytochroom P450 2C19 genotype op de effectiviteit van clopidogrel","authors":"P. Klaver","doi":"10.1007/BF03080061","DOIUrl":"https://doi.org/10.1007/BF03080061","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"160-160"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080061","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51872897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statines bij COPD; een systematisch overzicht 慢性阻塞性肺病的他汀类药物;系统概述
Medisch-farmaceutische mededelingen Pub Date : 2009-10-01 DOI: 10.1007/BF03080048
P. L. Bruijnzeel
{"title":"Statines bij COPD; een systematisch overzicht","authors":"P. L. Bruijnzeel","doi":"10.1007/BF03080048","DOIUrl":"https://doi.org/10.1007/BF03080048","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"151-152"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080048","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51872414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosering van antipsychotica bij ouderen 老年人抗精神病剂量
Medisch-farmaceutische mededelingen Pub Date : 2009-10-01 DOI: 10.1007/BF03080054
J. Sitsen
{"title":"Dosering van antipsychotica bij ouderen","authors":"J. Sitsen","doi":"10.1007/BF03080054","DOIUrl":"https://doi.org/10.1007/BF03080054","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"155-156"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080054","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51872743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutane bijwerkingen van anti-TNF behandeling 抗tnf治疗的皮肤副作用
Medisch-farmaceutische mededelingen Pub Date : 2009-10-01 DOI: 10.1007/BF03080065
P. L. Bruijnzeel
{"title":"Cutane bijwerkingen van anti-TNF behandeling","authors":"P. L. Bruijnzeel","doi":"10.1007/BF03080065","DOIUrl":"https://doi.org/10.1007/BF03080065","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"162-163"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080065","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51872952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信